EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Comprehensive analysis of extracellular matrix remodelling via cyclophilin inhibition in human models of alcohol‐related liver fibrosis

Una Rastovic, Sara Campinoti, Lai Wei, Bruna Almeida, Sergio Francesco Bozzano iD, Ramin Amiri iD, Nicola Harris, Omolola Ajayi, Tsin Shue Koay, Caoimhe Kerins, Fiona N Kenny, Ane Zamalloa and 13 more

British Journal of Pharmacology · 2025-11 · 182 (22) · 5647-5669

DOI: 10.1111/bph.70139 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2025-07-28. Written by Una Rastovic and 24 co-authors. Institution: Roger Williams Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London,…. Major MEDLINE topics: Extracellular Matrix, Cyclophilins, Liver Cirrhosis, Alcoholic, Liver Cirrhosis. Cited 3 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY 4.0). Funded by: Foundation for Liver Research, Hepion Pharmaceuticals, UK Engineering and Physical Sciences Research Council.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background and Purpose Chronic liver disease and hepatic fibrosis constitute a threat to global health. Clinical translation of preclinical research has been limited, highlighting an urgent need for novel treatments. Cyclophilin inhibitors have shown beneficial effects in liver disease; however, the underlying mechanism of action and the effect across different aetiologies remain elusive. Here, we investigate the impact of a pan‐cyclophilin inhibitor (rencofilstat, RCF) in human models of fibrosis and alcohol‐related liver disease. Experimental Approach RCF was tested in human precision‐cut liver slices (PCLS) and primary human hepatic stellate cells (HSCs). Fibrosis and cell activation were assessed using transcriptomic and protein analysis. A comprehensive characterisation of changes in extracellular matrix (ECM) biochemical and structural composition was performed in PCLS and HSC‐derived matrix using proteomics, imaging and bioinformatic tools to study ECM alignment. PCLS stiffness upon treatment was assessed by atomic force microscopy. Key Results Transcriptomic and proteomic analyses of PCLS revealed a dramatic impact of RCF on ECM organisation and remodelling. Biochemical composition and fibre alignment analysis of the ECM obtained from HSCs showed a reduction in the amount of ECM core proteins and associated enzymes by RCF, reshaping the architecture of matrix fibres without affecting the HSC activation. The disordered matrix detected in RCF‐treated HSC cultures reflected a less‐stiff ECM, which was confirmed in the PCLS. Conclusions and Implications This work provides evidence for a novel mechanism linking cyclophilins and ECM remodelling in advanced 3D models of liver disease, with potential applications in therapeutic development.

Subjects

MeSH terms (MEDLINE)

Extracellular MatrixCyclophilinsLiver Cirrhosis, AlcoholicLiver CirrhosisHumansHepatic Stellate CellsCells, CulturedLiverMale

Author keywords

cyclophilinsextracellular matrixhepatic stellate cellsliver fibrosisprecision‐cut liver slices

Substances

Cyclophilins

Authors and institutions

  • Roger Williams Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Foundation for Liver Research and King's College Hospital, London, UK.
  • Department of Civil, Chemical, Environmental and Materials Engineering (DICAM), University of Bologna, Bologna, Italy.
  • Centre for Craniofacial and Regenerative Biology, King's College London, London, UK.
  • Randall Centre for Cell and Molecular Biophysics, School of Basic and Medical Biosciences, Kings College London, London, UK.
  • Institute of Liver Studies, King's College London, London, UK.
  • Liver Histopathology Laboratory, Institute of Liver Studies, King's College Hospital, London, UK.

ORCID profiles: Sergio Francesco Bozzano, Ramin Amiri, Elena Palma

Funding

  • Foundation for Liver Research
  • Hepion Pharmaceuticals
  • UK Engineering and Physical Sciences Research Council
  • Wellcome Trust

Cite

APA

Rastovic, U., Campinoti, S., Wei, L., Almeida, B., Bozzano, S. F., Amiri, R., Harris, N., Ajayi, O., Koay, T. S., Kerins, C., Kenny, F. N., Zamalloa, A., Adofina, L., Miquel, R., Zen, Y., Srinivasan, P., Menon, K., Heaton, N., Luni, C., …, & Palma, E. (2025). Comprehensive analysis of extracellular matrix remodelling via cyclophilin inhibition in human models of alcohol‐related liver fibrosis. British Journal of Pharmacology, 182(22), 5647-5669. https://doi.org/10.1111/bph.70139

Vancouver

Rastovic U, Campinoti S, Wei L, Almeida B, Bozzano SF, Amiri R, et al. Comprehensive analysis of extracellular matrix remodelling via cyclophilin inhibition in human models of alcohol‐related liver fibrosis. British Journal of Pharmacology. 2025;182(22):5647-5669. doi:10.1111/bph.70139

BibTeX
@article{Rastovic2025,
  author = {Rastovic, Una and Campinoti, Sara and Wei, Lai and Almeida, Bruna and Bozzano, Sergio Francesco and Amiri, Ramin and Harris, Nicola and Ajayi, Omolola and Koay, Tsin Shue and Kerins, Caoimhe and Kenny, Fiona N and Zamalloa, Ane and Adofina, Lissette and Miquel, Rosa and Zen, Yoh and Srinivasan, Parthi and Menon, Krishna and Heaton, Nigel and Luni, Camilla and Gentleman, Eileen and Shaw, Tanya and Ure, Daren and Chokshi, Shilpa and Urbani, Luca and Palma, Elena},
  title = {Comprehensive analysis of extracellular matrix remodelling via cyclophilin inhibition in human models of alcohol‐related liver fibrosis},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {22},
  pages = {5647--5669},
  doi = {10.1111/bph.70139}
}
Start for free →